Skip to main content

Lipocine Inc. (LPCN)

NASDAQ: LPCN · IEX Real-Time Price · USD
1.10 -0.03 (-2.65%)
Nov 29, 2021 4:00 PM EST - Market closed

Total Valuation

Lipocine has a market cap or net worth of $97.12 million. The enterprise value is $61.59 million.

Market Cap97.12M
Enterprise Value61.59M

Important Dates

The latest earnings date was Tuesday, November 9, 2021 before market open.

Last Earnings DateNov 9, 2021
Ex-Dividend Daten/a

Share Statistics

Lipocine has 88.29 million shares outstanding. The number of shares has increased by 36.18% in one year.

Shares Outstanding88.29M
Shares Change (YoY)+36.18%
Shares Change (QoQ)n/a
Owned by Insiders (%)2.53%
Owned by Institutions (%)10.48%
Float86.08M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio1,766.00
PB Ratio2.96
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.

EV / Earningsn/a
EV / Sales1,120.00
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 6.28, with a Debt / Equity ratio of 0.10.

Current Ratio6.28
Quick Ratio6.01
Debt / Equity0.10
Debt / EBITDA-0.18
Debt / FCF-0.18

Financial Efficiency

Return on Equity (ROE)-56.30%
Return on Assets (ROA)-43.50%
Return on Capital (ROIC)-71.20%
Revenue Per Employee$4,999
Profits Per Employee-$1.62M
Employee Count11
Asset Turnover0.00
Inventory Turnovern/a

Taxes

In the past 12 months, Lipocine has paid $200 in taxes.

Income Tax200
Effective Tax Rate0.00%

Stock Price Statistics

. The beta is 0.38, so Lipocine's price volatility has been lower than the market average.

Beta (1Y)0.38
52-Week Price Changen/a
50-Day Moving Average1.12
200-Day Moving Average1.25
Average Volume (30 Days)816,593

Short Selling Information

Short Interest4.16M
Short % of Shares Out4.71%
Short % of Float4.83%
Short Ratio (days to cover)5.32

Income Statement

In the last 12 months, Lipocine had revenue of $54,994 and -$17.77 million in losses. Earnings per share was -$0.22.

Revenue54,994
Gross Profit54,994
Operating Income-14.44M
Pretax Income-17.77M
Net Income-17.77M
EBITDA-17.52M
EBIT-17.52M
Earnings Per Share (EPS)-$0.22
Full Income Statement

Balance Sheet

The company has $38.66 million in cash and $3.14 million in debt, giving a net cash position of $35.53 million or $0.40 per share.

Cash & Cash Equivalents38.66M
Total Debt3.14M
Net Cash35.53M
Net Cash Per Share$0.40
Book Value32.81M
Book Value Per Share0.37
Working Capital33.93M
Full Balance Sheet

Cash Flow

Operating Cash Flow-17.09M
Capital Expendituresn/a
Free Cash Flow-17.09M
FCF Per Share-$0.19
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -26,257.63% and -32,312.06%.

Gross Margin100.00%
Operating Margin-26,257.63%
Pretax Margin-32,311.70%
Profit Margin-32,312.06%
EBITDA Margin-31,850.69%
EBIT Margin-31,852.79%
FCF Margin-31,075.88%

Dividends & Yields

Lipocine does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-18.30%
FCF Yield-17.60%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

The last stock split was on July 25, 2013. It was a reverse split with a ratio of 1:100.

Last Split DateJul 25, 2013
Split TypeReverse
Split Ratio1:100